RA Capital Healthcare Fund LP
10% Owner; Director; Director, 10% Owner · 23 filings · Latest: May 12, 2026
Acrivon Therapeutics, Inc.
Acumen Pharmaceuticals, Inc.
Adicet Bio, Inc.
Artiva Biotherapeutics, Inc.
Bicara Therapeutics Inc.
Climb Bio, Inc.
Evommune, Inc.
Hemab Therapeutics Holdings, Inc.
Mineralys Therapeutics, Inc.
Prelude Therapeutics Inc
SpyGlass Pharma, Inc.
Vor Biopharma Inc.
Wave Life Sciences Ltd.
Werewolf Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
VOR | RA Capital Healthcare Fund LP | — | Oct 20, 2025 | Proposed Sale | $29.43 | 76,919 | $2.3M | — | |
VOR | RA Capital Healthcare Fund LP | — | Oct 17, 2025 | Proposed Sale | $29.00 | 218,043 | $6.3M | — | |
VOR | RA Capital Healthcare Fund LP | — | Oct 16, 2025 | Proposed Sale | $29.06 | 126,887 | $3.7M | — | |
VOR | RA Capital Healthcare Fund LP | — | Oct 15, 2025 | Proposed Sale | $30.22 | 42,933 | $1.3M | — |
← Previous
Page 3 of 3